169 related articles for article (PubMed ID: 8537338)
1. Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice.
Motokura T; Endo K; Kumaki K; Ogata E; Ikeda K
J Biol Chem; 1995 Dec; 270(52):30857-61. PubMed ID: 8537338
[TBL] [Abstract][Full Text] [Related]
2. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
Aklilu F; Park M; Goltzman D; Rabbani SA
Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related peptide is a downstream target for ras and src activation.
Li X; Drucker DJ
J Biol Chem; 1994 Mar; 269(9):6263-6. PubMed ID: 8119972
[TBL] [Abstract][Full Text] [Related]
4. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
5. Role of mitogen-activated protein kinases in the induction of parathyroid hormone-related peptide.
Aklilu F; Gladu J; Goltzman D; Rabbani SA
Cancer Res; 2000 Mar; 60(6):1753-60. PubMed ID: 10749150
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of the PTHrP gene in squamous carcinomas predicts the occurrence of hypercalcemia in athymic mice.
Wysolmerski JJ; Vasavada R; Foley J; Weir EC; Burtis WJ; Kukreja SC; Guise TA; Broadus AE; Philbrick WM
Cancer Res; 1996 Mar; 56(5):1043-9. PubMed ID: 8640759
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.
Yamato H; Nagai Y; Inoue D; Ohnishi Y; Ueyama Y; Ohno H; Matsumoto T; Ogata E; Ikeda K
J Bone Miner Res; 1995 Jan; 10(1):36-44. PubMed ID: 7747629
[TBL] [Abstract][Full Text] [Related]
10. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
11. Mouse embryo fibroblasts transformed by activated ras or dominant-negative p53 express cross-reactive tumor rejection antigens.
Appleman LJ; Uyeki J; Frey AB
Int J Cancer; 1995 Jun; 61(6):887-94. PubMed ID: 7540599
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53.
Foley J; Wysolmerski JJ; Broadus AE; Philbrick WM
Cancer Res; 1996 Sep; 56(17):4056-62. PubMed ID: 8752179
[TBL] [Abstract][Full Text] [Related]
13. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.
Zambetti GP; Olson D; Labow M; Levine AJ
Proc Natl Acad Sci U S A; 1992 May; 89(9):3952-6. PubMed ID: 1570319
[TBL] [Abstract][Full Text] [Related]
14. Activation of PTHrP gene expression in squamous carcinoma cell lines by mutant isoforms of the tumor suppressor p53.
Foley J; King CS; Jiménez JA; Wysolmerski JJ; Philbrick WM
Oncol Res; 2000; 12(2):71-81. PubMed ID: 11132926
[TBL] [Abstract][Full Text] [Related]
15. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
16. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
17. [Molecular biology of parathyroid hormone-related peptide].
Ikeda K
Nihon Rinsho; 1995 Apr; 53(4):835-43. PubMed ID: 7752469
[TBL] [Abstract][Full Text] [Related]
18. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
[TBL] [Abstract][Full Text] [Related]
19. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
Hinds P; Finlay C; Levine AJ
J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy.
Hwang CS; Park SY; Yu SH; Park JY; Park CT; Han KO
Gynecol Oncol; 2006 Nov; 103(2):740-4. PubMed ID: 16956653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
